Search This Blog

Tuesday, April 30, 2019

Merck narrows FY19 adjusted EPS view to $4.67-$4.79 from $4.57-$4.72

FY19 consensus $4.67. Narrows FY19 revenue view to $43.9B-$45.1B from $43.2B-$44.7B, consensus $44.42B.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)